Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer
- PMID: 16125874
- DOI: 10.1016/j.ijrobp.2005.04.052
Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer
Abstract
Purpose: Dynamic contrast-enhanced T1-weighted magnetic resonance imaging (DCE-MRI) allows noninvasive evaluation of tumor microvasculature characteristics. This study evaluated radiation therapy related microvascular changes in locally advanced rectal cancer by DCE-MRI and histology.
Methods and materials: Dynamic contrast-enhanced-MRI was performed in 17 patients with primary rectal cancer. Seven patients underwent 25 fractions of 1.8 Gy radiation therapy (RT) (long RT) before DCE-MRI and 10 did not. Of these 10, 3 patients underwent five fractions of 5 Gy RT (short RT) in the week before surgery. The RT treated and nontreated groups were compared in terms of endothelial transfer coefficient (K(PS), measured by DCE-MRI), microvessel density (MVD) (scored by immunoreactivity to CD31 and CD34), and tumor cell and endothelial cell proliferation (scored by immunoreactivity to Ki67).
Results: Tumor K(PS) was 77% (p = 0.03) lower in the RT-treated group. Histogram analyses showed that RT reduced both magnitude and intratumor heterogeneity of K(PS) (p = 0.01). MVD was significantly lower (37%, p = 0.03) in tumors treated with long RT than in nonirradiated tumors, but this was not the case with short RT. Endothelial cell proliferation was reduced with short RT (81%, p = 0.02) just before surgery, but not with long RT (p > 0.8). Tumor cell proliferation was reduced with both long (57%, p < 0.001) and short RT (52%, p = 0.002).
Conclusion: Dynamic contrast-enhanced-MRI-derived K(PS) values showed significant radiation therapy related reductions in microvessel blood flow in locally advanced rectal cancer. These findings may be useful in evaluating effects of radiation combination therapies (e.g., chemoradiation or RT combined with antiangiogenesis therapy), to account for effects of RT alone.
Similar articles
-
3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis.J Magn Reson Imaging. 2008 Jun;27(6):1309-16. doi: 10.1002/jmri.21378. J Magn Reson Imaging. 2008. PMID: 18504761
-
Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis.Br J Surg. 2006 Aug;93(8):992-1000. doi: 10.1002/bjs.5352. Br J Surg. 2006. PMID: 16673354
-
AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.Magn Reson Imaging. 2007 Apr;25(3):319-27. doi: 10.1016/j.mri.2006.09.041. Epub 2007 Feb 5. Magn Reson Imaging. 2007. PMID: 17371720
-
Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):770s-776s. doi: 10.1158/1078-0432.CCR-06-1921. Clin Cancer Res. 2007. PMID: 17255308 Review.
-
The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.Eur J Radiol. 2010 Dec;76(3):367-85. doi: 10.1016/j.ejrad.2010.01.026. Eur J Radiol. 2010. PMID: 20810230 Review.
Cited by
-
Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy.Target Oncol. 2010 Mar;5(1):39-52. doi: 10.1007/s11523-010-0135-8. Epub 2010 Apr 11. Target Oncol. 2010. PMID: 20383784 Review.
-
Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study.Eur Radiol. 2009 Jan;19(1):79-89. doi: 10.1007/s00330-008-1128-1. Epub 2008 Aug 15. Eur Radiol. 2009. PMID: 18704434
-
Radiomics: a new application from established techniques.Expert Rev Precis Med Drug Dev. 2016;1(2):207-226. doi: 10.1080/23808993.2016.1164013. Epub 2016 Mar 31. Expert Rev Precis Med Drug Dev. 2016. PMID: 28042608 Free PMC article.
-
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1837-44. doi: 10.1016/j.ijrobp.2011.03.006. Epub 2011 May 19. Int J Radiat Oncol Biol Phys. 2012. PMID: 21601373 Free PMC article.
-
Computational Modeling of Interstitial Fluid Pressure and Velocity in Non-small Cell Lung Cancer Brain Metastases Treated With Stereotactic Radiosurgery.Front Neurol. 2020 May 28;11:402. doi: 10.3389/fneur.2020.00402. eCollection 2020. Front Neurol. 2020. PMID: 32547470 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
